Division of Infectious Diseases

Aronoff to lead Division of Infectious Diseases

David Aronoff, M.D., has been named the new director of Vanderbilt University Medical Center’s Division of Infectious Diseases.

Preserving antibiotic arsenal for TB

Clinicians should be cautious about prescribing newer fluoroquinolone antibiotics to patients with TB risk factors; doing so may jeopardize the use of these agents against TB.

Talbot lands epidemiology award

Thomas Talbot, M.D., MPH, associate professor of Medicine and Chief Hospital Epidemiologist at Vanderbilt University Medical Center, received the 2013 Investigator Award from the Society for Healthcare Epidemiology of America (SHEA) at the organization’s Annual Scientific Meeting last week in San Francisco.

Vanderbilt researchers work to balance flu vaccine debate

Research in the last two years to examine the effectiveness of the influenza vaccine has raised public doubt about the flu shot’s effectiveness. But two Vanderbilt researchers co-wrote an editorial in the Journal of the American Medical Association (JAMA) recently to help balance the current debate.

New center to focus on treating, preventing TB

Vanderbilt University has established a tuberculosis center to expand and extend efforts to improve the treatment and prevention of this often fatal disease here and around the world.

Recruitments bolster personalized medicine initiative

VUMC’s personalized medicine effort is getting a major boost with the recruitment of two physician-scientists from Australia who will increase Vanderbilt’s strength in translational immunology, the translation of basic immunological discoveries into clinically useful tools.

1 11 12 13 14